Teriflunomide Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 7 mg and 14 mg tablets

Reference Brands: Aubagio(US & EU)

Category: Multiple sclerosis

Teriflunomide inhibits dihydroorotate dehydrogenase, blocking pyrimidine synthesis and reducing activated T and B cell proliferation. It decreases MS relapses, slows disease progression, and reduces lesion activity. Benefits include oral administration, disease stabilization, fewer relapses, and improved quality of life for patients with relapsing-remitting multiple sclerosis. Teriflunomide tablets is available in Tablet and strengths such as 7 mg and 14 mg tablets. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Teriflunomide tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Teriflunomide tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Teriflunomide tablets, marketed as Aubagio, are approved in the US by the FDA and in the EU via EMA for relapsing forms of multiple sclerosis (MS). Regulatory approval requires a comprehensive dossier including clinical trial data, safety profiles, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical and quality data for approval, while the EMA ensures compliance with regional safety and manufacturing standards.